((自动化翻译由路透提供，请见免责声明 ))
10月28日 - ** 药物开发商Evoke Pharma 的股价盘前翻了一番多，达到12.56美元。
** 该公司称，Gimoti是药物甲氧氯普胺的鼻喷雾剂，与口服甲氧氯普胺相比，给服用GLP-1减肥药的患者使用Gimoti能更好地减轻 (link)。
** EVOK公司称，Gimoti可用于治疗服用GLP-1药物的胃痉挛患者，胃痉挛是一种妨碍胃正常排空食物和液体的疾病。
** 截至上次收盘，股价累计下跌 58
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.